Asnières-sur-Seine, France
Asnières-sur-Seine, France

Time filter

Source Type

News Article | April 20, 2017
Site: www.prweb.com

As part of the Stago EdVantage Virtual University Virtual Event, this new webinar will explore challenging patient cases when screening for direct oral anticoagulant. When patients taking direct oral anticoagulants (DOACs) are admitted to the hospital, there may be a need for bridging parental anticoagulation especially for those at high risk of thrombosis recurrence. By presenting information on DOAC interference in laboratory assays, institutional experience, and case studies, this webinar will address questions surrounding management of patients on DOAC therapy. Attendees of this webinar will learn from instances when presented with challenging cases, and be able to show how traditional and other laboratory measures can help guide safe, appropriate therapy. Participants will also be able to gain a better understanding of how to identify the effects of DOACs, as well as describe common errors that are seen in practice when the effect of DOACs on common anticoagulation laboratory measures is not realized. The speaker for this event will be Dr. Michael P Gulseth, PharmD, BCPS, FASHP. He is the program director for Anticoagulation Services at Sanford USD Medical Center & Clinical. He is also an associate professor in the Department of Internal Medicine at the University of South Dakota Sanford School of Medicine. Gulseth is a recognized expert in the area of anticoagulation administration and safety, having developed the 2017 ISMP Medication Safety Self-Assessment for Antithrombotic Therapy. He has authored numerous peer-reviewed publications in this area. In addition, he regularly serves as an editor for publications and presents at conferences of the American Society of Health-System Pharmacists (ASHP). He was elected as a fellow of the ASHP in 2011 and serves on the editorial advisory board of American Journal of Health-System Pharmacy (AJHP). LabRoots will host the webinar April 26, 2017, commencing at 6:00 a.m. PDT. To learn more about the Stago EdVantage Virtual University Virtual Event, the continuing education credits offered, or to register for free, click here. ABOUT DIAGNOSTICA STAGO, INC. Diagnostica Stago, Inc. is the exclusive provider of the Diagnostica Stago Hemostasis product lines in the United States and offers a complete system of coagulation instruments and optimized reagent kits for research as well as for routine analysis. Diagnostica Stago, Inc. is the U.S. subsidiary of Diagnostica Stago, S.A.S. France, a leader in the development and manufacture of Hemostasis products. For more information about any Stago product or service, please call 800-222-COAG or visit our website at http://www.stago-us.com. ABOUT LABROOTS LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.


News Article | April 19, 2017
Site: www.prweb.com

As part of the Stago EdVantage Virtual University Virtual Event, which makes educational webinars accessible to novices as well as experienced users, attendees will gain a better understanding of the background and impact of preanalytical variables of commonly performed coagulation screening tests. Hemostasis testing quality is determined by preanalytical variables which encompass patient preparation, sample collection, handling, transportation, processing and storage. If any of the preanalytical variables are not properly adhered to, incorrect or uninterpretable results are reported resulting in possible adverse patient consequences or delays in treatment. Dr. John Mitsios, assistant director at the Special Coagulation Laboratory at BioReference Laboratories, will be the speaker for this event. Dr. Mitsios was recruited to BioReference Laboratories as an Assistant Director of the Special Coagulation Laboratory from a previous faculty position at Cornell University as an Assistant professor of Pathology and Laboratory Medicine as well as an Assistant Attending Clinical Chemist at New York-Presbyterian Hospital. In his current position, Dr. Mitsios is responsible for overseeing the day-to-day activities of the lab and signing out cases. The laboratory receives on average 150 – 200 patient specimens and performs roughly 1,000 tests per day. Dr. Mitsios has co-authored 19 peer-reviewed articles and 2 book chapters. LabRoots will host the webinar April 24, 2017, commencing at 6:00 a.m. PDT. To learn more about the Stago EdVantage Virtual University Virtual Event, the continuing education credits offered, or to register for free, click here. ABOUT DIAGNOSTICA STAGO, INC. Diagnostica Stago, Inc. is the exclusive provider of the Diagnostica Stago Hemostasis product lines in the United States and offers a complete system of coagulation instruments and optimized reagent kits for research as well as for routine analysis. Diagnostica Stago, Inc. is the U.S. subsidiary of Diagnostica Stago, S.A.S. France, a leader in the development and manufacture of Hemostasis products. For more information about any Stago product or service, please call 800-222-COAG or visit our website at http://www.stago-us.com. ABOUT LABROOTS LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.


This report studies sales (consumption) of Coagulation Testing Instrument in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Abbott Beckman Coulter Siemens Thermo Fisher Scientific BD ADI Axis-Shield Bio/Data Corporation Inverness Chrono-Log Corgenix Medical Diagnostica Stago Helena Laboratories Hyphen BioMed Instrumentation Laboratory Roche Sienco Sysmex View Full Report With Complete TOC, List Of Figure and Table: http://globalqyresearch.com/united-states-coagulation-testing-instrument-market-report-2016 Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Coagulation Testing Instrument in each application, can be divided into Application 1 Application 2 Application 3 United States Coagulation Testing Instrument Market Report 2016 1 Coagulation Testing Instrument Overview 1.1 Product Overview and Scope of Coagulation Testing Instrument 1.2 Classification of Coagulation Testing Instrument 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Application of Coagulation Testing Instrument 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 1.4 United States Market Size Sales (Value) and Revenue (Volume) of Coagulation Testing Instrument (2011-2021) 1.4.1 United States Coagulation Testing Instrument Sales and Growth Rate (2011-2021) 1.4.2 United States Coagulation Testing Instrument Revenue and Growth Rate (2011-2021) 5 United States Coagulation Testing Instrument Manufacturers Profiles/Analysis 5.1 Abbott 5.1.1 Company Basic Information, Manufacturing Base and Competitors 5.1.2 Coagulation Testing Instrument Product Type, Application and Specification 5.1.2.1 Type I 5.1.2.2 Type II 5.1.3 Abbott Coagulation Testing Instrument Sales, Revenue, Price and Gross Margin (2011-2016) 5.1.4 Main Business/Business Overview 5.2 Beckman Coulter 5.2.2 Coagulation Testing Instrument Product Type, Application and Specification 5.2.2.1 Type I 5.2.2.2 Type II 5.2.3 Beckman Coulter Coagulation Testing Instrument Sales, Revenue, Price and Gross Margin (2011-2016) 5.2.4 Main Business/Business Overview 5.3 Siemens 5.3.2 Coagulation Testing Instrument Product Type, Application and Specification 5.3.2.1 Type I 5.3.2.2 Type II 5.3.3 Siemens Coagulation Testing Instrument Sales, Revenue, Price and Gross Margin (2011-2016) 5.3.4 Main Business/Business Overview 5.4 Thermo Fisher Scientific 5.4.2 Coagulation Testing Instrument Product Type, Application and Specification 5.4.2.1 Type I 5.4.2.2 Type II 5.4.3 Thermo Fisher Scientific Coagulation Testing Instrument Sales, Revenue, Price and Gross Margin (2011-2016) 5.4.4 Main Business/Business Overview 5.5 BD 5.5.2 Coagulation Testing Instrument Product Type, Application and Specification 5.5.2.1 Type I 5.5.2.2 Type II 5.5.3 BD Coagulation Testing Instrument Sales, Revenue, Price and Gross Margin (2011-2016) 5.5.4 Main Business/Business Overview 5.6 ADI 5.6.2 Coagulation Testing Instrument Product Type, Application and Specification 5.6.2.1 Type I 5.6.2.2 Type II 5.6.3 ADI Coagulation Testing Instrument Sales, Revenue, Price and Gross Margin (2011-2016) 5.6.4 Main Business/Business Overview 5.7 Axis-Shield 5.7.2 Coagulation Testing Instrument Product Type, Application and Specification 5.7.2.1 Type I 5.7.2.2 Type II 5.7.3 Axis-Shield Coagulation Testing Instrument Sales, Revenue, Price and Gross Margin (2011-2016) 5.7.4 Main Business/Business Overview 5.8 Bio/Data Corporation 5.8.2 Coagulation Testing Instrument Product Type, Application and Specification 5.8.2.1 Type I 5.8.2.2 Type II 5.8.3 Bio/Data Corporation Coagulation Testing Instrument Sales, Revenue, Price and Gross Margin (2011-2016) 5.8.4 Main Business/Business Overview 5.9 Inverness 5.9.2 Coagulation Testing Instrument Product Type, Application and Specification 5.9.2.1 Type I 5.9.2.2 Type II 5.9.3 Inverness Coagulation Testing Instrument Sales, Revenue, Price and Gross Margin (2011-2016) 5.9.4 Main Business/Business Overview 5.10 Chrono-Log 5.10.2 Coagulation Testing Instrument Product Type, Application and Specification 5.10.2.1 Type I 5.10.2.2 Type II 5.10.3 Chrono-Log Coagulation Testing Instrument Sales, Revenue, Price and Gross Margin (2011-2016) 5.10.4 Main Business/Business Overview 5.11 Corgenix Medical 5.12 Diagnostica Stago 5.13 Helena Laboratories 5.14 Hyphen BioMed 5.15 Instrumentation Laboratory 5.16 Roche 5.17 Sienco 5.18 Sysmex Global QYResearch ( http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.


Patent
Diagnostica Stago | Date: 2014-12-09

A method of determining the position of at least one fixed cartography token (10) of an automaton, the token (10) including a base (11) having a lateral surface and an end face (14a), a stud (15) of smaller cross section than the base (11) projecting from the end face (14a) of the base (11), the stud (15) including an end face (16) opposite the base (11). The method is aimed in particular at deducing the coordinates (XO, YO, ZO) of at least one point (O) of the cartography token (10) with respect to a movable member.


A reaction vessel for an automatic chemical or biological analysis appliance includes a connection part (22) for connection to another vessel (10) of the same type, the connection part is resiliently snap-fastened on the top end of the vessel (10) and is also resiliently snap-fastened to the connection part (22) of another vessel so as to form a string of vessels that are hinged to one another about transverse axes (xx).


A method for adjusting the coagulation time during the manufacture of calibrators and controls produced from frozen plasma or plasma treated for lyophilization thereof, for haemostatis tests relating to assaying and to monitoring anticoagulant treatments in a patient. The plasmas selected to prepare the calibrator plasmas or the control plasmas are treated with a view to lyophilization and supplemented with different predefined doses of a drug and a procoagulant factor.


Trademark
Diagnostica Stago | Date: 2016-12-15

Non-titrated blood plasma for the conducting of laboratory tests of blood analysis apparatus. Providing of access to a website for the compilation of blood analysis results, providing and monitoring via the internet of data relating to comparative performance of the aforesaid blood analysis laboratories. Quality control of blood analysis and assistance for blood analysis laboratories for the qualitative improvement of their results.


Trademark
Diagnostica Stago | Date: 2016-07-08

Biological chemical products used for analyses, reactions, assays, testing in laboratories, for human and veterinary medicine, namely, laboratory reagents for assaying the factors of the endogenous pathway of blood coagulation, for human and veterinary medicine.


News Article | December 9, 2016
Site: marketersmedia.com

— The report "Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021” report provides a detailed overview of the major drivers, restraints, challenges, opportunities and strategies impacting the coagulation analyzer market along with the estimates and forecasts of the revenue and market share analysis. The coagulation analyzers market is projected to reach USD 4.84 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021. The major factor driving the growth of this market are increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide. The report segments this market based on product, test, technology, end-users, and regions. Among the products, the clinical laboratory analyzers are expected to account for the largest share of the market. The high growth of clinical laboratory analyzers can be attributed increasing rental agreements and increasing prevalence of blood related diseases worldwide. On the basis of type of test, the coagulation analyzers market is segmented into nine major test segments, namely, prothrombin time testing, fibrinogen testing, ACT, aPTT, d dimer testing, platelet function test, anti-factor Xa test, heparin & protamine dose response test for ACT and other coagulation tests. The prothrombin time testing is the largest test segment of this market, owing to the increasing incidence of cardiovascular and blood related diseases. Based on technology, the coagulation analyzers market is segmented into mechanical, optical, electrochemical and other technologies. The optical technology segment is expected to account for the largest share of the global coagulation analyzers market in 2016. This can be attributed to better flexibility and accuracy and greater application in coagulation analysis. Based on end-users, the coagulation analyzers market are clinical laboratories, PoC testing and others. The clinical laboratories segment is expected to account for the largest share of the global coagulation analyzers market in 2016. Rise in healthcare spending has resulted in the increasing use of coagulation analyzers market testing products in hospitals. Based on regions, the global coagulation analyzers market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in aging population, and increasing diseases due to urbanization in North America. Key players in the coagulation analyzers market include are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.). 1. Coagulation Analyzer and Consumable Manufacturers And Suppliers 2. Clinical Laboratories 3. Hospitals 4. Pharmaceutical and biotechnology companies 5. Academic research institutes related to coagulation testing market For more information, please visit http://www.marketsandmarkets.com/pdfdownload.asp?id=197226392


News Article | November 22, 2016
Site: www.prnewswire.co.uk

According to a new market research report "Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021" published by MarketsandMarkets, the market is projected to reach USD 4.84 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021. Browse 96 market data Tables and 57 Figures spread through 167 Pages and in-depth TOC on "Coagulation/Hemostasis Analyzer Market Early buyers will receive 10% customization on this report. This report provides a detailed overview of the major drivers, restraints, challenges, opportunities and strategies impacting the Coagulation Analyzers Market along with the estimates and forecasts of the revenue and market share analysis. The major factor driving the growth of this market are increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide. The report segments this market based on product, test, technology, end-users, and regions. Among the products, the clinical laboratory analyzers are expected to account for the largest share of the market. The high growth of clinical laboratory analyzers can be attributed increasing rental agreements and increasing prevalence of blood related diseases worldwide. On the basis of type of test, the Coagulation Analyzers Market is segmented into nine major test segments, namely, prothrombin time testing, fibrinogen testing, ACT, aPTT, d dimer testing, platelet function test, anti-factor Xa test, heparin & protamine dose response test for ACT and other coagulation tests. The prothrombin time testing is the largest test segment of this market, owing to the increasing incidence of cardiovascular and blood related diseases. Based on technology, the Coagulation Analyzers Market is segmented into mechanical, optical, electrochemical and other technologies. The optical technology segment is expected to account for the largest share of the global Coagulation Analyzers Market in 2016. This can be attributed to better flexibility and accuracy and greater application in coagulation analysis. Based on end-users, the Coagulation Analyzers Market are clinical laboratories, PoC testing and others. The clinical laboratories segment is expected to account for the largest share of the global Coagulation Analyzers Market in 2016.  Rise in healthcare spending has resulted in the increasing use of Coagulation Analyzers Market testing products in hospitals. Based on regions, the global Coagulation Analyzers Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in aging population, and increasing diseases due to urbanization in North America. Key players in the Coagulation Analyzers Market include are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.). MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

Loading Diagnostica Stago collaborators
Loading Diagnostica Stago collaborators